GlassScriptPhysician profile
John Orland Schorge
NPI 1669439923
$8,051.37
in general payments reported to CMS, 2019-2025
17 companies · $4,704 in 2025
The $4,704 reported for 2025 was more than what 86% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.70 · 2020: $80.95 · 2021: $215 · 2022: $21.80 · 2023: $2,695 · 2024: $309 · 2025: $4,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,398 · Food and Beverage: $2,022 · Travel and Lodging: $1,788 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,397.50 |
| Food and Beverage | $2,022.18 |
| Travel and Lodging | $1,787.86 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,419.35 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $2,397.50 | 2023 | Lynparza |
| Medtronic, INC. | $771.06 | 2023-2025 | Sonicision, Ligasure, Truclear |
| Coopersurgical, INC. | $296.53 | 2024-2025 | Ally II Ups, Advincula Delineator Uterine Manipulator |
| Ethicon US, LLC | $217.90 | 2021-2025 | Harmonic, Enseal |
| Glaxosmithkline, LLC. | $200.77 | 2020-2023 | Jemperli |
| Dilon Technologies, INC. | $146.23 | 2025 | Hemoblast Bellows |
| Eisai INC. | $142.75 | 2025 | |
| Biotissue Holdings INC. | $124.04 | 2025 | |
| Astellas Pharma US INC | $121.26 | 2024 | |
| Dentsply Ih INC. | $54.98 | 2021-2022 | |
| Pfizer INC. | $49.24 | 2020-2025 | |
| Kci USA, INC. | $41.38 | 2020 | |
| Corcept Therapeutics | $26.43 | 2025 | Korlym |
| Therapeuticsmd, INC. | $25.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $16.25 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schorge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.